Ono, Dainippon Sumitomo File For Approval Of Peripheral Circulation Drug Limaprost Alfadex In Japan
This article was originally published in PharmAsia News
Ono Pharmaceuticals and Dainippon Pharmaceuticals in Japan have both filed for the approval of a more stable formulation of the peripheral circulatory disorder drug limaprost alfadex.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Series C investment of an undisclosed amount announced in early May follows $20m funding for the Los Angeles company from Volition Capital and angel investors.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.